Brief: Adagene Announces Upcoming Poster Presentations On ADG126 At Society For Immunotherapy Of Cancer Annual Meeting
09/10/2024 12:05
Oct 9 (Reuters) - Adagene Inc 978y.F :
* ADAGENE ANNOUNCES UPCOMING POSTER PRESENTATIONS ON MASKED
ANTI-CTLA-4 SAFEBODY® ADG126 (MUZASTOTUG) AT SOCIETY FOR
IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
Source text for Eikon: ID:nGNX41Gxqq
Further company coverage: 978y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adagene
See all newsBrief: Adagene To Begin Phase 1 Study Of ADG138 For Advanced Solid Tumors In Q4 2026
Brief: Adagene Announces That Third Arc Bio Has Selected First Lead Candidate Under Amended Strategic Collaboration For Development Of Masked Cd3 T Cell Engagers Utilizing Safebody® Technology
Brief: Adagene Inc Announces Offering Of American Depositary Shares
Brief: Adagene Announces FDA Fast Track Designation For Muzastotug (Adg126)
Brief: Adagene Expands SAFEBody Deal With Exelixis To Develop Third Novel Masked Antibody-Drug Conjugate